Introduction: Min-Kuan Hsu, an accomplished inventor based in Yangmei, Taiwan, has made significant strides in the field of pharmaceuticals through his innovative processes and formulations. With a total of 11 patents to his name, Hsu's work is helping to advance the therapeutic landscape.

Latest Patents: Hsu's latest contributions to the field include a patent for an efficient crystallization process for preparing ultrapure Treprostinil. This invention presents a crystalline Form I of anhydrous Treprostinil, which features stable physicochemical properties beneficial for pharmaceutical formulations. This stability is advantageous for the safe storage, shipment, and handling of Treprostinil in commercial applications. Additionally, he has developed novel processes for the preparation of isomer-free prostaglandins. These processes focus on providing compounds substantially free of the 5,6-trans isomer, offering innovative intermediates for the preparation of prostaglandins and their derivatives.

Career Highlights: Hsu’s work at Chirogate International Inc. has been pivotal in driving innovations that contribute to safer and more effective pharmaceutical products. His expertise in synthesis and formulation has led to patents that are not only scientifically sound but also practically viable in commercial settings.

Collaborations: Throughout his career, Hsu has collaborated with talented coworkers, including Shih-Yi Wei and Yu-Chih Yeh. These collaborations have been instrumental in enriching the research and development processes at Chirogate International Inc., fostering an environment of innovation and teamwork.

Conclusion: Min-Kuan Hsu's dedication to advancing pharmaceutical science through innovation has been clearly demonstrated in his numerous patents and collaborative efforts. His contributions are pivotal in enhancing the safety and effectiveness of pharmaceutical products, solidifying his reputation as a notable inventor in the industry.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]